A new review finds that aspirin does not prevent colorectal cancer, contrary to earlier hopes about the drug's protective effects. Researchers analyzed existing evidence and concluded that taking aspirin regularly offers no real benefit for cancer prevention in this context.
The finding challenges a long-standing assumption in preventive medicine. Aspirin has shown promise for reducing heart attack and stroke risk in certain populations, but cancer prevention is not among its proven benefits.
What actually works for colorectal cancer prevention? Screening remains the gold standard. Regular colonoscopies detect precancerous polyps before they turn malignant. The American Cancer Society recommends screening starting at age 45 for average-risk adults.
Lifestyle changes also reduce colorectal cancer risk. Eating more fiber, exercising regularly, limiting red and processed meat, maintaining a healthy weight, and cutting back on alcohol all lower your odds. Smoking cessation matters too.
For people with a family history of colorectal cancer or genetic predisposition, genetic counseling and more aggressive screening strategies may apply. Your doctor can assess your individual risk and recommend the right approach.
Taking aspirin hoping it prevents cancer wastes your effort and exposes you to unnecessary side effects like bleeding. Instead, focus on proven strategies. Schedule your screening, eat well, move your body, and maintain healthy habits.
